FBInvestor
Stocks / Traws Pharma Inc
Institutional Ownership

Traws Pharma Inc

CUSIP 68232V884COM NEWTRAWQ1 2026

13D / 13G Filings
19
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
19.9%
Max % of class reported
Institutional Holders
24
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

19 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Squadron Master Fund LP13G/A8.9%713.5KSEC
2Feb 17, 2026Ikarian Capital, LLC13G/A11.0%812.5KSEC
3Feb 12, 2026Adage Capital Management, L.P.13G9.1%730.0KSEC
4Feb 11, 2026Ayrton Capital LLC13G/A4.3%342.9KSEC
5Jan 16, 2026Chernett Jorey13G6.8%543.3KSEC
6Nov 14, 2025Squadron Master Fund LP13G/A8.4%591.0KSEC
7Nov 14, 2025Perceptive Advisors LLC13G/A10.0%886.9KSEC
8Nov 13, 2025Adage Capital Management, L.P.13G/A4.7%330.0KSEC
9Sep 19, 2025Squadron Master Fund LP13G6.0%420.5KSEC
10May 15, 2025Ikarian Capital, LLC13G/A11.0%589.5KSEC

9 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Traws Pharma Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →